These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30614292)

  • 1. An update on current and emerging treatments for pulmonary arterial hypertension in childhood and adolescence.
    Wacker J; Weintraub R; Beghetti M
    Expert Rev Respir Med; 2019 Feb; 13(2):205-215. PubMed ID: 30614292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.
    Humpl T; Berger RMF; Austin ED; Fasnacht Boillat MS; Bonnet D; Ivy DD; Zuk M; Beghetti M; Schulze-Neick I
    Cardiol Young; 2017 Aug; 27(6):1123-1132. PubMed ID: 27995825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary arterial hypertension in children.
    Rosenzweig EB; Barst RJ
    Curr Opin Pediatr; 2005 Jun; 17(3):372-80. PubMed ID: 15891429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and advancing treatments for pulmonary arterial hypertension in childhood.
    Zijlstra WM; Ploegstra MJ; Berger RM
    Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today?
    Medarov BI; Judson MA
    Respir Med; 2015 May; 109(5):557-64. PubMed ID: 25666253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
    Tonelli AR; Alnuaimat H; Mubarak K
    Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of idiopathic/hereditary pulmonary arterial hypertension.
    Matsubara H; Ogawa A
    J Cardiol; 2014 Oct; 64(4):243-9. PubMed ID: 25082294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
    Oishi P; Datar SA; Fineman JR
    Expert Opin Pharmacother; 2011 Aug; 12(12):1845-64. PubMed ID: 21609302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of primary pulmonary hypertension.
    McLeod AA; Jewitt DE
    Drugs; 1986 Feb; 31(2):177-84. PubMed ID: 2868878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C
    Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for pulmonary arterial hypertension.
    Liu C; Liu K; Ji Z; Liu G
    Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.
    Kim JS; McSweeney J; Lee J; Ivy D
    Pediatr Crit Care Med; 2016 Mar; 17(3 Suppl 1):S89-100. PubMed ID: 26945333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator therapy for primary pulmonary hypertension.
    McGoon MD; Vlietstra RE
    Mayo Clin Proc; 1984 Oct; 59(10):672-7. PubMed ID: 6148467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary hypertension and right ventricular failure. Part IX. Traditional therapy of primary pulmonary arterial hypertension].
    Batyraliev TA; Makhmutkhodzhaev SA; Pataraia SA; Ekinci E; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV
    Kardiologiia; 2007; 47(4):74-82. PubMed ID: 18260847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatments for pulmonary arterial hypertension].
    Montani D; Jaïs X; Ioos V; Sitbon O; Simonneau G; Humbert M
    Rev Med Interne; 2004 Oct; 25(10):720-31. PubMed ID: 15471598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.